Artificial intelligence has invented two new potential antibiotics that could kill drug-resistant gonorrhoea and MRSA, researchers have revealed.
The drugs were designed atom-by-atom by the AI and killed the superbugs in laboratory and animal tests.
The two compounds still need years of refinement and clinical trials before they could be prescribed.
But the Massachusetts Institute of Technology (MIT) team behind it say AI could start a "second golden age" in antibiotic discovery. Learn more
A team at Massachusetts Institute of Technology (MIT) used generative AI algorithms to design more than 36 million possible compounds.
They also seemed to work in a new way - by disrupting bacterial cell membranes.
Antibiotics kill bacteria, but some infections have become resistant to drugs.
It is estimated that drug-resistant bacterial infections cause nearly five million deaths per year worldwide.
Two compounds were found to be effective against gonorrhoea and MRSA infections - namely NG1 and DN1, respectively. Learn more